Dainippon Sumitomo Of Japan Cleared To Market Diabetes Drug
This article was originally published in PharmAsia News
Executive Summary
Japan's Dainippon Sumitomo Pharma says Japanese authorities have approved its drug for reducing the amount of blood glucose in Type 2 diabetes patients following food intake